You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroblastoma

Showing 1 - 25 of 719
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial (GD2 CAR T cells)

Not yet recruiting
  • Neuroblastoma
  • GD2 CAR T cells
  • (no location specified)
Aug 5, 2023

Neuroblastoma Patients

Not yet recruiting
  • Neuroblastoma
    • San Francisco, California
      Power Life Sciences
    Jun 15, 2023

    Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

    Recruiting
    • Neuroblastoma
    • Ganglioneuroblastoma
    • monoclonal antibodies GD2
    • Moscow, Russian Federation
      Research Institute of Pediatric Hematology, Oncology and Immunol
    Oct 4, 2023

    Neuroblastoma Trial (Naxitamab)

    Not yet recruiting
    • Neuroblastoma
    • (no location specified)
    Sep 18, 2023

    Refractory Neuroblastoma, Relapsed Neuroblastoma, High-risk Neuroblastoma Trial (GPC2 CAR T cells)

    Not yet recruiting
    • Refractory Neuroblastoma
    • +2 more
    • GPC2 CAR T cells
    • (no location specified)
    Dec 21, 2022

    Neuroblastoma Trial in Copenhagen (18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT))

    Recruiting
    • Neuroblastoma
    • 18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT)
    • Copenhagen, Denmark
      Rigshospitalet, Copenhagen University Hospital
    Apr 11, 2023

    Neuroblastoma, High-risk Neuroblastoma, Metastatic Neuroblastoma Trial in United States (OPT-821 (QS-21), oral ß-glucan)

    Recruiting
    • Neuroblastoma
    • +2 more
    • OPT-821 (QS-21)
    • oral β-glucan
    • Basking Ridge, New Jersey
    • +6 more
    Sep 21, 2023

    Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

    Recruiting
    • Neuroblastoma Recurrent
    • Natural killer cell
    • +4 more
    • Hong Kong, Hong Kong
      Hong Kong Children's Hospital
    Feb 22, 2023

    Neuroblastoma Trial in Esplugues De Llobregat (Immersive virtual reality imaging, Gold standard imaging)

    Recruiting
    • Neuroblastoma
    • Immersive virtual reality imaging
    • Gold standard imaging
    • Esplugues De Llobregat, Barcelona, Spain
      Hospital Sant Joan de Déu
    Mar 23, 2023

    Children and Adults With Olfactory Neuroblastoma

    Recruiting
    • Olfactory Neuroblastoma
    • Esthesioneuroblastoma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023

      Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

      Recruiting
      • Neuroblastoma
      • Naxitamab monotherapy
      • +6 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Aug 31, 2023

      Neuroblastoma, Pediatric Solid Tumor Trial in Boston (procedure, biological, drug)

      Recruiting
      • Neuroblastoma
      • Pediatric Solid Tumor
      • Tissue collection
      • +3 more
      • Boston, Massachusetts
      • +1 more
      Oct 17, 2022

      Neuroblastoma, Solid Tumor Trial (APG-115, APG-2575)

      Not yet recruiting
      • Neuroblastoma
      • Solid Tumor
      • (no location specified)
      Jan 18, 2023

      Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

      Recruiting
      • Neuroblastoma
      • Pediatric Cancer
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 11, 2023

      Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma Trial in Atlanta (Ex Vivo Expanded Allogeneic ?d T Cells in

      Not yet recruiting
      • Neuroblastoma
      • +2 more
      • Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate
      • Atlanta, Georgia
        Children's Healthcare of Atlanta
      Oct 6, 2022

      Neuroblastoma Trial in Montréal, Sherbrooke (Radiopharmaceutical 68Ga-DOTATATE)

      Recruiting
      • Neuroblastoma
      • Radiopharmaceutical 68Ga-DOTATATE
      • Montréal, Quebec, Canada
      • +2 more
      Jan 3, 2023

      Neuroblastoma Trial in Moscow, Saint Petersburg (BCD-245)

      Recruiting
      • Neuroblastoma
      • BCD-245
      • Moscow, Russian Federation
      • +2 more
      Mar 13, 2023

      Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

      Active, not recruiting
      • Neuroblastoma
      • GINAKIT Cells
      • +2 more
      • Houston, Texas
        Texas Children's Hospital
      Jan 18, 2023

      Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)

      Terminated
      • Neuroblastoma
      • Cancer
      • Biopsy
      • +12 more
      • Philadelphia, Pennsylvania
        The Children's Hospital of Philadelphia
      Jan 31, 2023

      Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

      Recruiting
      • Neuroblastoma
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Nov 2, 2022

      Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

      Active, not recruiting
      • Neuroblastoma Survivors
      • Urine sample
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Aug 12, 2022

      Neuroblastoma Trial in New York (dietary supplement, drug, biological)

      Recruiting
      • Neuroblastoma
      • β-glucan
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Dec 5, 2022

      B7-H3-positive Relapsed/ Refractory Neuroblastoma Trial in Tianjin (T cell injection targeting FLT3 chimeric antigen receptor)

      Not yet recruiting
      • B7-H3-positive Relapsed/ Refractory Neuroblastoma
      • T cell injection targeting FLT3 chimeric antigen receptor
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Institute and Hospital
      Nov 1, 2022

      Neuroblastoma in Children Trial in Guangzhou (Tucidinostat and etoposide)

      Recruiting
      • Neuroblastoma in Children
      • Tucidinostat and etoposide
      • Guangzhou, China
        Sun Yat-sen University
      Jun 9, 2022

      High-risk Neuroblastoma Trial in China (Dinutuximab Beta, 13 cis retinoic acid)

      Active, not recruiting
      • High-risk Neuroblastoma
      • Dinutuximab Beta
      • 13 cis retinoic acid
      • Beijing, Beijing, China
      • +3 more
      Dec 7, 2022